Availability. Subject to the terms and conditions of this Agreement, on the Effective Date, Bank shall make one (1) term loan advance to Borrower in an original principal amount equal to Thirty Million Dollars ($30,000,000) (the “Term Loan Advance”).

Availability. Subject to the terms and conditions of this Agreement, upon Borrower’s request, Bank shall make one (1) term loan advance (the “Term Loan Advance”) to Borrower, on or about the Effective Date, in an original principal amount of Fourteen Million Dollars ($14,000,000.00). After repayment, the Term Loan Advance (or any portion thereof) may not be reborrowed.

Availability. Subject to the terms and conditions of this Agreement, upon Borrower’s request, the Lenders, severally and not jointly, shall make one (1) term loan advance to Borrower on or about the Effective Date in an original principal amount of Fifteen Million Dollars ($15,000,000.00) according to each Lender’s Term A Loan Advance Commitment as set forth on [Schedule 1.1] hereto (the “Term A Loan Advance”). Subject to the terms and conditions of this Agreement, upon Borrower’s request, during the Draw Period, the Lenders, severally and not jointly, shall make one (1) term loan advance available to Borrower in an original principal amount of Ten Million Dollars ($10,000,000.00) according to each Lender’s Term A Loan Advance Commitment as set forth on [Schedule 1.1] hereto (the “Term B Loan Advance”). The Term A Loan Advance and the Term B Loan Advance are hereinafter referred to singly as a “Term Loan Advance” and collectively as the “Term Loan Advances”. After repayment, no Term Loan Advance (or any portion thereof) may be reborrowed.

Subject to the terms and conditions of this Agreement, beginning on the First Amendment Effective Date and continuing through the Amortization Date, and conditioned on approval by the Lenders’ investment committee in its sole and unfettered discretion, Borrower may request additional Term Loan Advances in an aggregate principal amount up to Thirty Million Dollars ($30,000,000), in minimum increments of Ten Million Dollars ($10,000,000) (each, a “Tranche 3 Advance”).

Availability. Subject to the terms and conditions of this Agreement, upon Borrower’s request, during the Draw Period, Bank shall make advances (each, a “Term B Loan Advance” and collectively, the “Term B Loan Advances”) available to Borrower in an aggregate original principal amount not to exceed the Term B Loan Commitment Amount. Each Term B Loan Advance must be in an amount equal to at least Three Million Dollars ($3,000,000.00), or if there is a lesser amount remaining available under the Term B Loan Commitment Amount, the entire amount remaining available under the Term B Loan Commitment Amount. After repayment, no Term B Loan Advance (or any portion thereof) may be reborrowed. The Term A Loan and Term B Loan Advances, shall hereinafter each be referred to singly as the “Term Loan” and collectively as the “Term Loans.”

Availability. Subject to the terms and conditions of this Agreement, upon Borrower’s request, Bank shall make one (1) advance to Borrower on the Effective Date in the original principal amount of Twenty-Five Million Dollars ($25,000,000.00) (the “Term A Loan”), provided that all or a portion of the proceeds of the Term A Loan shall be used by Borrower to repay in full Borrower’s outstanding obligations and liabilities to Solar Capital Ltd. After repayment, the Term A Loan (or any portion thereof) may not be reborrowed.

Availability. Subject to the terms and conditions of this Agreement, on the Effective Date Borrower shall request and Bank shall make one (1) term loan advance available to Borrower in the original principal amount of Thirty-Five Million Dollars ($35,000,000.00) (the “Term Loan Advance”); provided that, the proceeds of the Term Loan Advance shall be used to repay in full Borrower’s outstanding obligations and liabilities to BioPharma Secured Investments III Holdings Cayman LP (“BioPharma”), including, without limitation, obligations and liabilities outstanding under the BioPharma Loan Agreement (the “BioPharma Obligations”). Any proceeds of the Term Loan Advance remaining after payment in full of the BioPharma Obligations shall be used for working capital and general corporate purposes. After repayment, the Term Loan Advance (or any portion thereof) may not be reborrowed.

Availability. Bank shall make a single term loan available to Borrower in an amount up to the Term Loan Amount on or about the Effective Date subject to the satisfaction of the terms and conditions of this Agreement (the “Term Loan”).

“(i) Availability. Subject to the terms and conditions of this Agreement, the Bank agrees to make a term loan to Borrower on the Third Amendment Effective Date, or as soon thereafter as practical, in the amount of Fifteen Million Dollars ($15,000,000.00) (the “Term Loan”). After repayment, the Term Loan may not be reborrowed. Upon the extension of the Term Loan pursuant to this [Section 2.1(a)(i)], Bank has no further obligations to make Credit Extensions.

Availability. Subject to the terms and conditions of this Agreement (including Sections 3.1 and 3.3), Lender agrees to make a term loan to Borrower on the Funding Date in a principal amount (the “Term Loan Amount”) of One Hundred Fifty Million Dollars ($150,000,000.00), in exchange for a note with an initial principal amount equal to such Term Loan Amount (the “Term Loan”). After repayment, no part of the Term Loan may be re-borrowed.